Alternatives to DeepCure

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

AI-powered platform for predicting drug efficacy and safety, reducing clinical trial failures.

Digital therapeutics platform enhancing drug efficacy and safety through personalized software.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Develops human antibodies targeting functional epitopes for challenging therapeutic areas using AI-driven computational design.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

N-Power Medicine is a healthcare technology company transforming oncology drug development and community cancer patient care.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

Develops a computational model of the human body for drug discovery and development.

Variantyx is a precision medicine company offering comprehensive genomic testing solutions for rare genetic disorders, reproductive health, and oncology.

Ukko is developing novel food allergy and disorder treatments using advanced immunology and plant science.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

AI-powered platform connecting cancer patients to advanced treatments and clinical trials.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Microbiome drug discovery company developing customized phage therapies for chronic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.